Deutsche Bank
AKCA

Deutsche Bank’s Akcea Therapeutics Inc AKCA Stock Holding History

Deutsche Bank’s Portfolio AKCA Stock Details AKCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-8,759
Closed -$159K – 4641
2020
Q3 		$159K Buy
8,759
+800
+10% +$11.3K ﹤0.01% 3334
2020
Q2 		$109K Buy
7,959
+3,608
+83% +$55.7K ﹤0.01% 3398
2020
Q1 		$63K Sell
4,351
-7,255
-63% -$119K ﹤0.01% 3442
2019
Q4 		$195K Buy
11,606
+7,791
+204% +$145K ﹤0.01% 3241
2019
Q3 		$57K Sell
3,815
-844
-18% -$18K ﹤0.01% 3870
2019
Q2 		$107K Sell
4,659
-777
-14% -$19.2K ﹤0.01% 4179
2019
Q1 		$153K Buy
5,436
+1,066
+24% +$31K ﹤0.01% 4143
2018
Q4 		$130K Sell
4,370
-37,699
-90% -$1.06M ﹤0.01% 4097
2018
Q3 		$1.47M Sell
42,069
-7,718
-16% -$234K ﹤0.01% 3045
2018
Q2 		$1.18M Buy
49,787
+18,317
+58% +$437K ﹤0.01% 3312
2018
Q1 		$804K Sell
31,470
-3,154
-9% -$67.9K ﹤0.01% 3436
2017
Q4 		$600K Buy
34,624
+5,134
+17% +$101K ﹤0.01% 3508
2017
Q3 		$814K Buy
+29,490
New +$546K ﹤0.01% 3156

Deutsche Bank's AKCA Position: Q4 2020 in Review

Deutsche Bank sold out of Akcea Therapeutics Inc (AKCA) in Q4 2020, closing a stake of 8,759 shares — an estimated $159K sold.

Deutsche Bank first reported a position in AKCA in Q3 2017 and held it in 13 quarters. The position peaked at $1.47M in Q3 2018. 0 funds tracked by Wall St. Rank hold AKCA as of Q4 2020.

  • Deutsche Bank reported no remaining Akcea Therapeutics Inc position as of Q4 2020 after selling out during the quarter.
  • Deutsche Bank sold 8,759 Akcea Therapeutics Inc shares in Q4 2020, an estimated $159K.
  • Deutsche Bank first reported a position in Akcea Therapeutics Inc in Q3 2017 and held it in 13 quarters.
  • Deutsche Bank's Akcea Therapeutics Inc position peaked at $1.47M in Q3 2018.
  • 0 funds tracked by Wall St. Rank held Akcea Therapeutics Inc as of Q4 2020.

Based on Deutsche Bank's 13F filing for Q4 2020, filed 16 Feb 2021.